Alcon

Company ALC

Last mentioned: Mar 19, 2026

Timeline

  1. BOJ Decision

    Anticipated interest rate decision from the Bank of Japan expected to impact global liquidity.

  2. Japan Trade Data

    Japan announces a surprise ¥57.269 billion trade surplus for February.

  3. BofA Hyperscaler Forecast

    Bank of America raises bond issuance outlook for cloud giants.

  4. Commerzbank Rejection

    Commerzbank board formally rejects UniCredit's exchange offer.

  5. Retail Resilience

    Five Below reports strong Q4 results; Alcon and LENSAR scrap merger plans.

  6. Market Downturn

    Asian markets follow Wall Street lower amid global economic uncertainty.

  7. JBS USA Strike

    Workers at the Colorado beef plant walk off the job, disrupting production.

  8. Merger Termination

    Alcon and LENSAR end their merger agreement due to FTC regulatory hurdles.

  9. Getty Earnings

    Getty Images releases mixed financial results showing a Q4 loss but FY25 revenue growth.

  10. Market Slide

    Asian markets open lower, following a downward trend from Wall Street indices.

  11. Getty Earnings

    Getty Images releases FY25 results showing annual revenue growth despite a Q4 loss.

  12. Merger Collapse

    Alcon and LENSAR terminate their merger agreement after failing to overcome FTC antitrust hurdles.

  13. JBS Strike

    Labor strike begins at JBS USA's Colorado facility, impacting regional supply chains.

  14. Deal Termination

    Alcon and LENSAR announce the end of the merger agreement due to FTC opposition.

  15. Getty Images Earnings

    Getty reports FY25 revenue growth despite a Q4 net loss.

  16. Alcon-LENSAR Termination

    Merger cancelled following FTC regulatory opposition.

  17. Market Downturn

    Asian markets track Wall Street lower amid geopolitical concerns and inflation fears.

  18. 2026 Strategic Focus

    Strategic focus shifts toward AI-integrated ophthalmic surgical suites for the 2026 fiscal year.

  19. Q4 2025 Earnings Report

    Alcon reports Q4 2025 earnings, beating analyst expectations in key segments.

  20. FTC Investigation

    The FTC intensifies its review of the merger, focusing on the ophthalmic laser market.

Stories mentioning Alcon 18

earnings Bearish

Hyperscaler Debt Surge and Getty AI Pivot Drive Global Market Sentiment

Bank of America has significantly raised its bond issuance forecast for hyperscale cloud providers, signaling a massive capital injection into AI infrastructure. Meanwhile, Getty Images reported rising full-year revenue despite a quarterly loss, highlighting the complex financial transition for AI-integrated content platforms.

11 sources
market-trends Bearish

Global Markets Pull Back as FTC Blocks Alcon-LENSAR Merger

Asian markets followed Wall Street's downward trend as regulatory headwinds and mixed corporate earnings dampened investor sentiment. The collapse of the Alcon-LENSAR merger and Getty Images' Q4 loss highlight the current challenges for tech-driven growth and consolidation.

5 sources
medical-devices Bearish

Alcon Abandons LENSAR Acquisition Following FTC Antitrust Challenges

Alcon has officially terminated its merger agreement with LENSAR, a leader in femtosecond laser technology, citing insurmountable opposition from the Federal Trade Commission (FTC). The collapse of the deal highlights increasing regulatory scrutiny over consolidation within the specialized medical device and ophthalmic surgery sectors.

5 sources
regulation Bearish

FTC Scrutiny Derails Alcon-LENSAR Merger Amid Global Market Volatility

Alcon has terminated its planned acquisition of LENSAR following opposition from the Federal Trade Commission, highlighting intensified antitrust enforcement in the medical technology sector. Simultaneously, labor unrest at JBS USA and mixed earnings from Getty Images underscore broader economic pressures as global markets trend downward.

5 sources
earnings Neutral

CooperCompanies and Rumble Deliver Steady Q4 Results Amid Market Volatility

CooperCompanies and Rumble both reported fourth-quarter 2025 financial results that met analyst expectations, signaling operational stability in the medical device and digital media sectors. While both firms navigated macroeconomic headwinds, their ability to hit consensus targets provides a floor for investor sentiment heading into the 2026 fiscal year.

2 sources
earnings Neutral

Industrial SaaS and AI Integration Drive Q4 2025 Earnings Across Sectors

The Q4 2025 earnings cycle reveals a significant shift as industrial giants like Astec and Lineage integrate SaaS-based monitoring, while tech firms like Taboola and Hippo leverage AI for record efficiency. This convergence indicates that digital transformation is now the primary driver of margin expansion across both hardware and software sectors.

6 sources
earnings Neutral

Infrastructure and Healthcare Resilience Anchor Q4 2025 Earnings Cycle

The Q4 2025 earnings reports from leaders in infrastructure, healthcare, and logistics reveal a resilient corporate landscape despite persistent macro-economic headwinds. Companies like Astec and Alcon are leveraging operational efficiencies and non-discretionary demand to drive margin expansion and long-term growth.

6 sources
adtech Neutral

Taboola Leads AdTech Recovery as Q4 Earnings Signal Shift to AI-Driven Growth

A wave of Q4 2025 earnings reports, led by AdTech giant Taboola and InsurTech disruptor Hippo, reveals a strengthening digital advertising market and a pivot toward AI-integrated performance marketing. While industrial players like Astec and Lineage signal macro stability, the marketing sector is increasingly defined by efficiency gains and high-intent audience targeting.

6 sources
earnings Neutral

Allison Transmission and Alcon Miss Q4 Estimates as Industrial Demand Cools

Allison Transmission reported a significant Q4 earnings miss, posting $1.18 per share against a $1.55 estimate, while Alcon narrowly missed expectations with a core EPS of $0.78. These results highlight a divergence in sectoral resilience, with heavy-duty industrials facing sharper headwinds than the healthcare and vision care markets.

2 sources